Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney.

Increase in matrix protein content in the kidney is a cardinal feature of diabetic kidney disease. While renal matrix protein content is increased by chronic hyperglycemia, whether it is regulated by acute elevation of glucose and insulin has not been addressed. In this study, we aimed to evaluate whether short duration of combined hyperglycemia and hyperinsulinemia, mimicking the metabolic environment of prediabetes and early type 2 diabetes, induces kidney injury. Normal rats were subjected to either saline infusion (control, n = 4) or 7 h of combined hyperglycemic-hyperinsulinemic clamp (HG+HI clamp; n = 6). During the clamp, plasma glucose and plasma insulin were maintained at about 350 mg/dl and 16 ng/ml, respectively. HG+HI clamp increased the expression of renal cortical transforming growth factor-β (TGF-β) and renal matrix proteins, laminin and fibronectin. This was associated with the activation of SMAD3, Akt, mammalian target of rapamycin (mTOR) complexes, and ERK signaling pathways and their downstream target events in the initiation and elongation phases of mRNA translation, an important step in protein synthesis. Additionally, HG+HI clamp provoked renal inflammation as shown by the activation of Toll-like receptor 4 (TLR4) and infiltration of CD68-positive monocytes. Urinary F2t isoprostane excretion, an index of renal oxidant stress, was increased in the HG+HI clamp rats. We conclude that even a short duration of hyperglycemia and hyperinsulinemia contributes to activation of pathways that regulate matrix protein synthesis, inflammation, and oxidative stress in the kidney. This finding could have implications for the control of short-term rises in blood glucose in diabetic individuals at risk of developing kidney disease.

[1]  K. Suszták,et al.  The hyperglycemic and hyperinsulinemic combo gives you diabetic kidney disease immediately. Focus on "Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney". , 2014, American journal of physiology. Cell physiology.

[2]  G. Reiter,et al.  Short-Term Hyperinsulinemia and Hyperglycemia Increase Myocardial Lipid Content in Normal Subjects , 2012, Diabetes.

[3]  A. Elmarakby,et al.  Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. , 2012, Cardiovascular therapeutics.

[4]  H. Abboud,et al.  Hydrogen Sulfide Inhibits High Glucose-induced Matrix Protein Synthesis by Activating AMP-activated Protein Kinase in Renal Epithelial Cells*♦ , 2011, The Journal of Biological Chemistry.

[5]  S. Gygi,et al.  mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. , 2011, Molecular cell.

[6]  C. Lang,et al.  Deptor Knockdown Enhances mTOR Activity and Protein Synthesis in Myocytes and Ameliorates Disuse Muscle Atrophy , 2011, Molecular medicine.

[7]  Christos G. Gkogkas,et al.  mRNA helicases: the tacticians of translational control , 2011, Nature Reviews Molecular Cell Biology.

[8]  R. Tibbetts,et al.  Regulation of Ribosomal Protein S6 Phosphorylation by Casein Kinase 1 and Protein Phosphatase 1* , 2011, The Journal of Biological Chemistry.

[9]  J. Scholey,et al.  The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes , 2010, Diabetes Care.

[10]  R. DeFronzo Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 , 2010, Diabetologia.

[11]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[12]  D. Féliers,et al.  Regulation of mRNA translation in renal physiology and disease. , 2009, American journal of physiology. Renal physiology.

[13]  D. Sabatini,et al.  DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.

[14]  K. Node,et al.  Postprandial hyperglycemia as an etiological factor in vascular failure , 2009, Cardiovascular diabetology.

[15]  K. Sharma,et al.  Transcription factors in the pathogenesis of diabetic nephropathy , 2009, Expert Reviews in Molecular Medicine.

[16]  A. Ceriello Postprandial Hyperglycemia and Cardiovascular Disease , 2009, Diabetes Care.

[17]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[18]  R. Roeder,et al.  Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia , 2008, The Journal of Experimental Medicine.

[19]  S. Maeda Do inflammatory cytokine genes confer susceptibility to diabetic nephropathy? , 2008, Kidney international.

[20]  D. Féliers,et al.  Novel mechanisms of protein synthesis in diabetic nephropathy—role of mRNA translation , 2008, Reviews in Endocrine and Metabolic Disorders.

[21]  D. Riley,et al.  Raptor-rictor axis in TGFβ-induced protein synthesis , 2008 .

[22]  T. van der Poll,et al.  Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[23]  J. O’Keefe,et al.  Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events? , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  D. Riley,et al.  Raptor-rictor axis in TGFbeta-induced protein synthesis. , 2008, Cellular signalling.

[25]  W. W. Lautt,et al.  Postprandial insulin resistance as an early predictor of cardiovascular risk , 2007, Therapeutics and clinical risk management.

[26]  E. Bottinger TGF-β in renal injury and disease , 2007 .

[27]  D. Féliers,et al.  High Glucose, High Insulin, and Their Combination Rapidly Induce Laminin-β1 Synthesis by Regulation of mRNA Translation in Renal Epithelial Cells , 2007, Diabetes.

[28]  B. Viollet,et al.  A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. , 2007, American journal of physiology. Renal physiology.

[29]  K. Inoki,et al.  mTOR pathway as a target in tissue hypertrophy. , 2007, Annual review of pharmacology and toxicology.

[30]  E. Böttinger TGF-beta in renal injury and disease. , 2007, Seminars in nephrology.

[31]  Y. Zhang,et al.  Improvement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats , 2008, Inflammation Research.

[32]  Michele Pagano,et al.  S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.

[33]  N. Hasebe,et al.  Hyperinsulinemia is an independent predictor for complex atherosclerotic lesion of thoracic aorta in non-diabetic patients. , 2006, Atherosclerosis.

[34]  Brian Raught,et al.  The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity , 2006, The EMBO journal.

[35]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[36]  Michael Brownlee,et al.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.

[37]  H. Abboud,et al.  Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. , 2006, American journal of physiology. Renal physiology.

[38]  B. Falkner,et al.  Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[39]  Michele Pagano,et al.  S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. , 2006, Science.

[40]  Robert T. Abraham,et al.  Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase* , 2005, Journal of Biological Chemistry.

[41]  J. Egido,et al.  NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  G. Fulcher,et al.  Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. , 2004, American journal of physiology. Renal physiology.

[43]  A. Cavarape,et al.  The post‐prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[44]  G. King,et al.  Molecular understanding of hyperglycemia's adverse effects for diabetic complications. , 2002, JAMA.

[45]  R. Marfella,et al.  Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.

[46]  A. Gingras,et al.  Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells. , 2001, Kidney international.

[47]  J. Petrik,et al.  The Renal Expression of Transforming Growth Factor-β Isoforms and Their Receptors in Acute and Chronic Experimental Diabetes in Rats. , 2000, Endocrinology.

[48]  J. Petrik,et al.  The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. , 2000, Endocrinology.

[49]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[50]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[51]  S. Haffner The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. , 1998, Endocrine reviews.

[52]  H. Abboud,et al.  Expression of Transforming Growth Factor-β and Type IV Collagen in Early Streptozotocin-Induced Diabetes , 1997, Diabetes.

[53]  H. Abboud,et al.  Erratum: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes (Diabetes (1997) 46 (473- 480)) , 1997 .

[54]  H. Abboud,et al.  Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. , 1997, Diabetes.

[55]  L. Luzi,et al.  Different Sensitivity of Glucose and Amino Acid Metabolism to Insulin in NIDDM , 1993, Diabetes.

[56]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.